Article Text

PDF
85 Newly Diagnosed, Treatment-Naive Patients with Rheumatoid Arthritis have early Abnormalities of Vascular and Myocardial Function
  1. Bara Erhayiem,
  2. Adam McDiarmid,
  3. Peter Swoboda,
  4. Ananth Kidambi,
  5. David Ripley,
  6. Tarique Al Musa,
  7. Laura Dobson,
  8. Pankaj Garg,
  9. Jacqueline Andrews,
  10. John Greenwood,
  11. Maya Buch,
  12. Sven Plein
  1. University of Leeds

Abstract

Background Rheumatoid arthritis (RA) is a common autoimmune disease. Mortality is increased compared to the general population largely due to increased cardiovascular disease (CVD). Immune dysregulation and systemic inflammation are thought to be associated with this increased risk. CMR can provide an assessment of CVD, including myocardial and vascular morphology and function, but it is unknown which CMR measurements are most sensitive to detect early CVD.

Objectives To determine CV manifestations of RA using CMR in newly diagnosed, treatment-naive patients compared with matched controls.

Method Fifty-two RA patients fulfilling ACR/EULAR classification RA criteria, without CVD history, underwent CMR at 3.0T (Philips Achieva TX). They had symptoms for less than 1 year, had not yet received therapy with any disease modifying anti-rheumatic drugs, disease activity score (DAS28) ≥ 3.2 and at least one RA poor prognostic factor. 30 healthy controls were matched by age, sex and blood pressure. Standard balanced steady state free precession (SSFP) cine images were acquired and LV dimensions calculated. Strain analysis was performed by tissue-tagging using a spatial modulation of magnetization pulse sequence. For aortic distensibility (AD), multi-phase SSFP cine images (50 phases) were acquired in a plane transverse to the ascending aorta at the level of the pulmonary artery bifurcation. Aortic contours were drawn by manual planimetry of the endovascular–blood pool interface at the times of minimal and maximal distension. Native and 15 min post-contrast T1 maps were generated from mid-LV short axis using a modified 3,3,5 Look-Locker inversion sequence to calculate extra-cellular volume fraction (ECV).

Results Participant characteristics are presented in Table 1.

Abstract 85 Table 1

Participant characteristics according to Rheumatoid Arthritis status. Data presented as mean ± SD unless otherwise stated. ACPA = anti-citrullinated peptide antibody, CRP = C-reactive protein, DAS = Disease activity score, ESR = Erythrocyte sedimentation rate, RA = Rheumatoid arthritis, RF = Rheumatoid factor

Aortic distensibility was reduced in RA patients compared to controls (mean±SD, 3.23 ± 1.6 10–3 mmHg-1 vs. 4.99 ± 1.8 10–3 mmHg-1, p = 0.001). Other measures of arterial stiffness including aortic stiffness index, compliance and strain showed differences with similar significance levels. Left ventricular remodelling was not different in the RA group compared with controls, but S’ was lower in RA (mean±SD, 0.99 ± 0.22 Seconds-1 vs. 1.13 ± 0.16 Seconds-1, p = 0.007) which may signify sub-clinical reduction in myocardial performance. Evidence for overt inflammation/fibrosis was seen in 4 patients with areas of focal non-ischaemic patterns of LGE, but native T1 and ECV was not different between the groups. See Table 2.

Abstract 85 Table 2

CMR findings between RA patients and controls. Data presented as mean ± SD unless otherwise stated. ECV = extra-cellular volume, EDV = End-diastolic volume, EF = Ejection fraction, LGE = Late-gadolinium enhancement, LV = Left ventricle, S’ = Peak systolic strain rate

Conclusion Early abnormal subclinical changes in vascular and myocardial function exist in newly diagnosed, treatment-naive RA patients, without overt changes in ventricular performance and geometry. The natural history of these observations and implications in the wider management of RA warrant further investigation.

  • Rheumatoid
  • Aortic distensibility
  • Extra-cellular volume fraction

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.